I. Kade Karisma Gita Ardana
This is a likely match — the affiliation was inferred from OpenAlex, ORCID, and web sources but has not been fully confirmed. Treat with appropriate caution.
Senior Graduate Assistant
Also affiliated: State University of Malang (2018–2022); Universitas Gadjah Mada (2020); Universitas Tribhuwana Tunggadewi (2020); Rumah Sakit Umum Pusat Dr. Sardjito (2020)
Research Areas
Biomedical Subjects
Links
Biography and Research Information
OverviewAI-generated summary
I. Kade Karisma Gita Ardana's research focuses on cellular senescence and mesenchymal stem cells, particularly investigating genomic biomarkers for stem cell scalability and the implications of genotype on cellular senescence phenotypes. Ardana has explored the effects of Dasatinib on mesenchymal stem/stromal cells and has published on genetic profiling in breast cancer, examining Wnt and BRCA pathways.
Additional research interests include skeletal malocclusions in the Javanese population, analyzing single-nucleotide polymorphisms in genes like COL1A1 and FGFR2. Ardana has also contributed to studies on rice genetics, specifically investigating gene polymorphisms related to submergence and salinity tolerance in Indonesian local varieties. The researcher has also analyzed variations in the SARS-CoV-2, SARS-CoV, and MERS-CoV genomes and spike proteins.
Metrics
- h-index: 3
- Publications: 16
- Citations: 20
Positions
-
Senior Graduate Assistant publications 2025–2026University of Arkansas at Fayetteville Institution web page
Selected Publications
-
Validation of a novel genomic biomarker of mesenchymal stem cell scalability and implications of genotype status on cellular senescence phenotypes (2026)
-
Validation of a Novel Genomic Biomarker of Mesenchymal Stem Cell Scalability and Implications of Genotype Status on Cellular Senescence Phenotypes (2025)
-
Correction: Assessing the Effects of Dasatinib on Mesenchymal Stem/Stromal Cells (2024)
-
Assessing the Effects of Dasatinib on Mesenchymal Stem/Stromal Cells (2024)
Collaboration Network
Top Collaborators
- Assessing the Effects of Dasatinib on Mesenchymal Stem/Stromal Cells
- Correction: Assessing the Effects of Dasatinib on Mesenchymal Stem/Stromal Cells
- Validation of a Novel Genomic Biomarker of Mesenchymal Stem Cell Scalability and Implications of Genotype Status on Cellular Senescence Phenotypes
- Validation of a novel genomic biomarker of mesenchymal stem cell scalability and implications of genotype status on cellular senescence phenotypes
- Assessing the Effects of Dasatinib on Mesenchymal Stem/Stromal Cells
- Correction: Assessing the Effects of Dasatinib on Mesenchymal Stem/Stromal Cells
- Validation of a novel genomic biomarker of mesenchymal stem cell scalability and implications of genotype status on cellular senescence phenotypes
- Assessing the Effects of Dasatinib on Mesenchymal Stem/Stromal Cells
- Correction: Assessing the Effects of Dasatinib on Mesenchymal Stem/Stromal Cells
- Assessing the Effects of Dasatinib on Mesenchymal Stem/Stromal Cells
- Correction: Assessing the Effects of Dasatinib on Mesenchymal Stem/Stromal Cells
- Validation of a Novel Genomic Biomarker of Mesenchymal Stem Cell Scalability and Implications of Genotype Status on Cellular Senescence Phenotypes
- Validation of a Novel Genomic Biomarker of Mesenchymal Stem Cell Scalability and Implications of Genotype Status on Cellular Senescence Phenotypes
- Validation of a novel genomic biomarker of mesenchymal stem cell scalability and implications of genotype status on cellular senescence phenotypes
Similar Researchers
Based on overlapping research topics